FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200612034> ?p ?o ?g. }

• W3200612034 endingPage "1831" @default.
• W3200612034 startingPage "1818" @default.
• W3200612034 abstract "Age-related chronic low-grade inflammation (inflammaging) is one of the proposed mechanisms behind sarcopenia. However, findings regarding inflammatory markers in sarcopenic older adults are conflicting. This study aimed to determine the association between inflammatory markers, prevalent as well as incident sarcopenia, sarcopenia-defining parameters, quality of life (QoL), and physical activity in middle-aged and older men.Men aged 40-79 years (mean 59.66 ± 11.00y) were recruited from population registers in eight European centres for participation in the European Male Aging study (EMAS). Subjects were assessed at baseline (2003-2005) and again after a median follow-up of 4.29 years. In 2577 participants, associations between baseline inflammatory markers [high-sensitive C-reactive protein (hs-CRP), white blood cell count (WBC), albumin] and baseline physical activity (PASE) and QoL (SF-36) were analysed. In the Leuven and Manchester cohort (n = 447), data were available on muscle mass (whole-body dual X-ray absorptiometry) and strength. In this subgroup, cross-sectional associations between baseline inflammatory markers and sarcopenia-defining parameters (handgrip strength, chair stand test, appendicular lean mass, and gait speed) and prevalent sarcopenia were examined. In a further subgroup (n = 277), associations with knee extensor strength were explored. Longitudinally, predictive value of baseline inflammation on functional decline, physical activity, QoL, and incident sarcopenia was examined. Subgroup analyses were performed in subgroups with chronic inflammation and stratified by age. Linear and logistic regressions were used, adjusted for age, body mass index, centre, and smoking.At baseline, hs-CRP and WBC were negatively associated with PASE score (hs-CRP: β = -7.920, P < 0.001; and WBC: β = -4.552, P < 0.001) and the physical component score of SF-36 (hs-CRP: β = -1.025, P < 0.001; and WBC: β = -0.364, P < 0.001). Baseline WBC levels were negatively associated with gait speed (β = -0.013; P = 0.025), quadriceps isometric 90° (β = -5.983; P = 0.035) and isokinetic 60°/s peak torque/body weight (β = -5.532; P = 0.027). The prevalence of sarcopenia at baseline was 18.1% (n = 81). Of those without sarcopenia at baseline, 64 (18.6%) satisfied criteria for sarcopenia at follow-up. There were no significant associations between baseline inflammatory markers and either prevalent or incident sarcopenia, or change in level of sarcopenia-defining parameters between baseline and follow-up.In middle-aged and older men, hs-CRP and WBC were negatively associated with QoL and PASE scores, while WBC was negatively associated with gait speed and knee strength. Associations with hs-CRP remained significant in all ages, whereas WBC levels were only associated with PASE, gait speed and knee strength in older adults (60-79 years). Baseline inflammatory markers (hs-CRP, WBC and albumin) did not predict functional decline, decline in physical activity, decreased QoL or incident sarcopenia." @default.
• W3200612034 created "2021-09-27" @default.
• W3200612034 creator A5024945442 @default.
• W3200612034 creator A5029868091 @default.
• W3200612034 creator A5031600540 @default.
• W3200612034 creator A5042078236 @default.
• W3200612034 creator A5043593248 @default.
• W3200612034 creator A5044078730 @default.
• W3200612034 creator A5047432027 @default.
• W3200612034 creator A5049129057 @default.
• W3200612034 creator A5049759930 @default.
• W3200612034 creator A5049854527 @default.
• W3200612034 creator A5054245942 @default.
• W3200612034 creator A5056026612 @default.
• W3200612034 creator A5065682345 @default.
• W3200612034 creator A5079566710 @default.
• W3200612034 creator A5080001826 @default.
• W3200612034 creator A5080465451 @default.
• W3200612034 creator A5088392007 @default.
• W3200612034 date "2021-09-15" @default.
• W3200612034 modified "2023-10-14" @default.
• W3200612034 title "Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)" @default.
• W3200612034 cites W1499546297 @default.
• W3200612034 cites W1584397506 @default.
• W3200612034 cites W1921376977 @default.
• W3200612034 cites W1968913466 @default.
• W3200612034 cites W1971454445 @default.
• W3200612034 cites W2005375523 @default.
• W3200612034 cites W2022296025 @default.
• W3200612034 cites W2089607347 @default.
• W3200612034 cites W2102902846 @default.
• W3200612034 cites W2106956157 @default.
• W3200612034 cites W2110839189 @default.
• W3200612034 cites W2114629409 @default.
• W3200612034 cites W2116294028 @default.
• W3200612034 cites W2121335554 @default.
• W3200612034 cites W2124405724 @default.
• W3200612034 cites W2134939550 @default.
• W3200612034 cites W2154946570 @default.
• W3200612034 cites W2159294672 @default.
• W3200612034 cites W2159718291 @default.
• W3200612034 cites W2171267283 @default.
• W3200612034 cites W2262352538 @default.
• W3200612034 cites W2416122254 @default.
• W3200612034 cites W2460931195 @default.
• W3200612034 cites W2553464641 @default.
• W3200612034 cites W2616778070 @default.
• W3200612034 cites W2734377645 @default.
• W3200612034 cites W2775422686 @default.
• W3200612034 cites W2792452569 @default.
• W3200612034 cites W2894242585 @default.
• W3200612034 cites W2897513125 @default.
• W3200612034 cites W2905229149 @default.
• W3200612034 cites W2934729223 @default.
• W3200612034 cites W2956377711 @default.
• W3200612034 cites W2971074815 @default.
• W3200612034 cites W2982669953 @default.
• W3200612034 cites W3032725120 @default.
• W3200612034 cites W3039429901 @default.
• W3200612034 cites W3090249126 @default.
• W3200612034 cites W3097144605 @default.
• W3200612034 cites W4292806894 @default.
• W3200612034 doi "https://doi.org/10.1002/jcsm.12785" @default.
• W3200612034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34523822" @default.
• W3200612034 hasPublicationYear "2021" @default.
• W3200612034 type Work @default.
• W3200612034 sameAs 3200612034 @default.
• W3200612034 citedByCount "17" @default.
• W3200612034 countsByYear W32006120342022 @default.
• W3200612034 countsByYear W32006120342023 @default.
• W3200612034 crossrefType "journal-article" @default.
• W3200612034 hasAuthorship W3200612034A5024945442 @default.
• W3200612034 hasAuthorship W3200612034A5029868091 @default.
• W3200612034 hasAuthorship W3200612034A5031600540 @default.
• W3200612034 hasAuthorship W3200612034A5042078236 @default.
• W3200612034 hasAuthorship W3200612034A5043593248 @default.
• W3200612034 hasAuthorship W3200612034A5044078730 @default.
• W3200612034 hasAuthorship W3200612034A5047432027 @default.
• W3200612034 hasAuthorship W3200612034A5049129057 @default.
• W3200612034 hasAuthorship W3200612034A5049759930 @default.
• W3200612034 hasAuthorship W3200612034A5049854527 @default.
• W3200612034 hasAuthorship W3200612034A5054245942 @default.
• W3200612034 hasAuthorship W3200612034A5056026612 @default.
• W3200612034 hasAuthorship W3200612034A5065682345 @default.
• W3200612034 hasAuthorship W3200612034A5079566710 @default.
• W3200612034 hasAuthorship W3200612034A5080001826 @default.
• W3200612034 hasAuthorship W3200612034A5080465451 @default.
• W3200612034 hasAuthorship W3200612034A5088392007 @default.
• W3200612034 hasBestOaLocation W32006120341 @default.
• W3200612034 hasConcept C126322002 @default.
• W3200612034 hasConcept C151956035 @default.
• W3200612034 hasConcept C159110408 @default.
• W3200612034 hasConcept C1862650 @default.
• W3200612034 hasConcept C2776214593 @default.
• W3200612034 hasConcept C2776914184 @default.
• W3200612034 hasConcept C2779951463 @default.
• W3200612034 hasConcept C2780221984 @default.
• W3200612034 hasConcept C2781195455 @default.

• next